Found: 14
Select item for more details and to access through your institution.
Cafestol, a coffee-specific diterpene, induces peripheral antinociception mediated by endogenous opioid peptides.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 412, doi. 10.1111/j.1440-1681.2012.05689.x
- By:
- Publication type:
- Article
Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 423, doi. 10.1111/j.1440-1681.2012.05691.x
- By:
- Publication type:
- Article
KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 462, doi. 10.1111/j.1440-1681.2012.05701.x
- By:
- Publication type:
- Article
2,3,4′,5- Tetrahydroxystilbene-2- O-β- d-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 429, doi. 10.1111/j.1440-1681.2012.05692.x
- By:
- Publication type:
- Article
Anti-inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine?
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 404, doi. 10.1111/j.1440-1681.2012.05695.x
- By:
- Publication type:
- Article
Mechanisms mediating propofol protection of pulmonary epithelial cells against lipopolysaccharide-induced cell death.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 447, doi. 10.1111/j.1440-1681.2012.05694.x
- By:
- Publication type:
- Article
On the reversal of liver cirrhosis: mystery or reality?
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 401, doi. 10.1111/j.1440-1681.2012.05698.x
- By:
- Publication type:
- Article
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 454, doi. 10.1111/j.1440-1681.2012.05699.x
- By:
- Publication type:
- Article
Comparison of the organization of t-tubules, sarcoplasmic reticulum and ryanodine receptors in rat and human ventricular myocardium.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 469, doi. 10.1111/j.1440-1681.2011.05578.x
- By:
- Publication type:
- Article
Expression of myostatin, myostatin receptors and follistatin in diabetic rats submitted to exercise.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 417, doi. 10.1111/j.1440-1681.2012.05690.x
- By:
- Publication type:
- Article
Downregulation of vasopressin V<sub>1A</sub> receptors and activation of mitogen-activated protein kinase in rat mesangial cells cultured under high-glucose conditions.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 438, doi. 10.1111/j.1440-1681.2012.05693.x
- By:
- Publication type:
- Article
Caption: A tricolour overlay of the ryanodine receptor (red), caveolin-3 (green) and sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA, blue) in a rat ventricular myocyte. See Jayasinghe et al. pp 469-476.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. i, doi. 10.1111/j.1440-1681.2012.05711.x
- Publication type:
- Article
Proteins within the intracellular calcium store determine cardiac Ry R channel activity and cardiac output.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 477, doi. 10.1111/j.1440-1681.2012.05704.x
- By:
- Publication type:
- Article
Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 5, p. 406, doi. 10.1111/j.1440-1681.2012.05670.x
- By:
- Publication type:
- Article